Holdings of Invesco Nasdaq Biotechnology ETF
Invesco Exchange-Traded Fund Trust II · Original filing · Compare with another fund · Report an error
- Net assets
- 67.4M $ including 67.3M $ in equities, 99.9 %
- Positions
- 254 in 18 countries
- Top ten
- 40.7 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 37,039 | 5M $ | 7.39 % |
| 2 | Vertex Pharmaceuticals Inc | 11,104 | 5M $ | 7.38 % |
| 3 | Amgen Inc | 14,213 | 4.8M $ | 7.10 % |
| 4 | Regeneron Pharmaceuticals Inc | 5,570 | 3.4M $ | 5.08 % |
| 5 | ALNYLAM PHARMACEUTICALS INC | 7,110 | 2.1M $ | 3.19 % |
| 6 | REVOLUTION MEDICINES INC | 10,624 | 1.7M $ | 2.48 % |
| 7 | Biogen Inc | 7,868 | 1.5M $ | 2.29 % |
| 8 | Illumina Inc | 8,197 | 1.3M $ | 1.98 % |
| 9 | United Therapeutics Corp | 2,350 | 1.3M $ | 1.94 % |
| 10 | ROYALTY PHARMA PLC | 22,968 | 1.3M $ | 1.90 % |
| 11 | Argenx SE | 1,521 | 1.3M $ | 1.89 % |
| 12 | Insmed Inc | 11,556 | 1.2M $ | 1.83 % |
| 13 | Roivant Sciences Ltd | 38,370 | 1.2M $ | 1.71 % |
| 14 | Incyte Corp | 10,669 | 1M $ | 1.53 % |
| 15 | VIATRIS INC | 61,728 | 1M $ | 1.49 % |
| 16 | MODERNA INC | 21,173 | 999.2K $ | 1.48 % |
| 17 | GUARDANT HEALTH INC | 7,032 | 912K $ | 1.35 % |
| 18 | Neurocrine Biosciences Inc | 5,381 | 851.8K $ | 1.26 % |
| 19 | JAZZ PHARMACEUTICALS PLC | 3,300 | 780.4K $ | 1.16 % |
| 20 | Ascendis Pharma A/S | 3,301 | 739.8K $ | 1.10 % |
| 21 | Summit Therapeutics Inc | 41,569 | 729.1K $ | 1.08 % |
| 22 | Exelixis Inc | 13,923 | 702.8K $ | 1.04 % |
| 23 | Bridgebio Pharma Inc | 10,393 | 688.6K $ | 1.02 % |
| 24 | Medpace Holdings Inc | 1,522 | 680.5K $ | 1.01 % |
| 25 | IONIS PHARMACEUTICALS INC | 8,856 | 677.5K $ | 1.01 % |
| 26 | Axsome Therapeutics Inc | 2,742 | 642.9K $ | 0.95 % |
| 27 | Madrigal Pharmaceuticals Inc | 1,230 | 611.6K $ | 0.91 % |
| 28 | BioMarin Pharmaceutical Inc | 10,311 | 590.7K $ | 0.88 % |
| 29 | BioNTech SE | 6,112 | 586.4K $ | 0.87 % |
| 30 | Arrowhead Pharmaceuticals Inc | 7,507 | 584.9K $ | 0.87 % |
| 31 | SANOFI SA | 13,122 | 573K $ | 0.85 % |
| 32 | Praxis Precision Medicines Inc | 1,493 | 522.5K $ | 0.78 % |
| 33 | CYTOKINETICS INC | 6,597 | 506.4K $ | 0.75 % |
| 34 | BEONE MEDICINES LTD | 1,714 | 493.5K $ | 0.73 % |
| 35 | Krystal Biotech Inc | 1,567 | 484.3K $ | 0.72 % |
| 36 | Tempus AI Inc | 9,314 | 470.1K $ | 0.70 % |
| 37 | ABIVAX SA | 3,294 | 436.9K $ | 0.65 % |
| 38 | Nuvalent Inc | 3,923 | 433.1K $ | 0.64 % |
| 39 | Halozyme Therapeutics Inc | 6,327 | 421K $ | 0.62 % |
| 40 | IMMUNITYBIO INC | 55,119 | 414.5K $ | 0.62 % |
| 41 | VAXCYTE INC | 7,716 | 396.6K $ | 0.59 % |
| 42 | Alkermes PLC | 8,934 | 376.9K $ | 0.56 % |
| 43 | IMMUNOVANT INC | 10,912 | 363.4K $ | 0.54 % |
| 44 | KYMERA THERAPEUTICS INC | 4,377 | 356.4K $ | 0.53 % |
| 45 | Protagonist Therapeutics Inc | 3,421 | 340.6K $ | 0.51 % |
| 46 | MIRUM PHARMACEUTICALS INC | 3,235 | 328.4K $ | 0.49 % |
| 47 | PTC Therapeutics Inc | 4,433 | 327.4K $ | 0.49 % |
| 48 | Rhythm Pharmaceuticals Inc | 3,661 | 323.3K $ | 0.48 % |
| 49 | Spyre Therapeutics Inc | 4,207 | 309.2K $ | 0.46 % |
| 50 | COGENT BIOSCIENCES INC | 8,702 | 304.2K $ | 0.45 % |
| 51 | CRISPR Therapeutics AG | 5,136 | 288.5K $ | 0.43 % |
| 52 | CG ONCOLOGY INC | 4,527 | 282K $ | 0.42 % |
| 53 | Scholar Rock Holding Corp | 5,458 | 269.1K $ | 0.40 % |
| 54 | Centessa Pharmaceuticals PLC | 6,401 | 254.5K $ | 0.38 % |
| 55 | CARIS LIFE SCIENCES INC | 15,091 | 252.3K $ | 0.37 % |
| 56 | Ligand Pharmaceuticals Inc | 1,069 | 248K $ | 0.37 % |
| 57 | Xenon Pharmaceuticals Inc | 4,455 | 243.8K $ | 0.36 % |
| 58 | Indivior Pharmaceuticals Inc | 6,697 | 241.2K $ | 0.36 % |
| 59 | Apogee Therapeutics Inc | 2,933 | 240.9K $ | 0.36 % |
| 60 | TRAVERE THERAPEUTICS INC | 4,947 | 233.4K $ | 0.35 % |
| 61 | Amneal Pharmaceuticals Inc | 16,863 | 222.1K $ | 0.33 % |
| 62 | TWIST BIOSCIENCE CORP | 3,287 | 219.8K $ | 0.33 % |
| 63 | Erasca Inc | 16,597 | 213.1K $ | 0.32 % |
| 64 | NEWAMSTERDAM PHARMA COMPANY NV | 6,171 | 207.8K $ | 0.31 % |
| 65 | Crinetics Pharmaceuticals Inc | 5,613 | 199.5K $ | 0.30 % |
| 66 | ACADIA Pharmaceuticals Inc | 9,144 | 198.1K $ | 0.29 % |
| 67 | Veracyte Inc | 4,260 | 197.4K $ | 0.29 % |
| 68 | Edgewise Therapeutics Inc | 5,751 | 196.5K $ | 0.29 % |
| 69 | Beam Therapeutics Inc | 5,461 | 179.8K $ | 0.27 % |
| 70 | Denali Therapeutics Inc | 8,502 | 178.9K $ | 0.27 % |
| 71 | 10X Genomics Inc | 6,309 | 178.6K $ | 0.27 % |
| 72 | DYNE THERAPEUTICS INC | 8,827 | 170.6K $ | 0.25 % |
| 73 | STRUCTURE THERAPEUTICS INC | 4,176 | 164.3K $ | 0.24 % |
| 74 | Tango Therapeutics Inc | 7,220 | 158.7K $ | 0.24 % |
| 75 | ORUKA THERAPEUTICS INC | 2,595 | 151.9K $ | 0.23 % |
| 76 | GRAIL Inc | 2,094 | 150.1K $ | 0.22 % |
| 77 | ALUMIS INC | 6,778 | 146.4K $ | 0.22 % |
| 78 | Arcutis Biotherapeutics Inc | 6,650 | 142.7K $ | 0.21 % |
| 79 | Disc Medicine Inc | 2,046 | 142.3K $ | 0.21 % |
| 80 | Supernus Pharmaceuticals Inc | 3,074 | 142K $ | 0.21 % |
| 81 | Ideaya Biosciences Inc | 4,708 | 138.7K $ | 0.21 % |
| 82 | VERA THERAPEUTICS INC | 3,825 | 135.9K $ | 0.20 % |
| 83 | TARSUS PHARMACEUTICALS INC | 2,282 | 135.6K $ | 0.20 % |
| 84 | Relay Therapeutics Inc | 9,582 | 134.6K $ | 0.20 % |
| 85 | Mineralys Therapeutics Inc | 4,243 | 133.7K $ | 0.20 % |
| 86 | Definium Therapeutics Inc | 5,345 | 129.3K $ | 0.19 % |
| 87 | Enliven Therapeutics Inc | 3,182 | 125.9K $ | 0.19 % |
| 88 | Adaptive Biotechnologies Corp | 8,255 | 125.1K $ | 0.19 % |
| 89 | Ultragenyx Pharmaceutical Inc | 5,180 | 124K $ | 0.18 % |
| 90 | LEGEND BIOTECH CORP | 4,525 | 122.9K $ | 0.18 % |
| 91 | Kodiak Sciences Inc | 3,273 | 120.2K $ | 0.18 % |
| 92 | BioCryst Pharmaceuticals Inc | 13,446 | 119.8K $ | 0.18 % |
| 93 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 2,461 | 119.1K $ | 0.18 % |
| 94 | Aurinia Pharmaceuticals Inc | 7,129 | 109.3K $ | 0.16 % |
| 95 | OCULAR THERAPEUTIX INC | 11,671 | 105.2K $ | 0.16 % |
| 96 | Pharvaris NV | 3,443 | 103.8K $ | 0.15 % |
| 97 | Novocure Ltd | 6,072 | 103.5K $ | 0.15 % |
| 98 | Sionna Therapeutics Inc | 2,393 | 102.5K $ | 0.15 % |
| 99 | ADMA Biologics Inc | 12,768 | 101.9K $ | 0.15 % |
| 100 | Rapport Therapeutics Inc | 2,574 | 101.7K $ | 0.15 % |
Sector breakdown
- Health care 46.5 %
- Unattributed 53.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.7 %
- Netherlands 2.5 %
- Ireland 1.9 %
- Bermuda 1.7 %
- France 1.5 %
- Denmark 1.2 %
- Germany 0.9 %
- Canada 0.7 %
- United Kingdom 0.5 %
- Switzerland 0.4 %
- Cayman Islands 0.3 %
- Jersey 0.2 %
- Other countries 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 217 | 59M $ | 87.65 % |
| 2 | Netherlands | 4 | 1.7M $ | 2.49 % |
| 3 | Ireland | 4 | 1.3M $ | 1.88 % |
| 4 | Bermuda | 1 | 1.2M $ | 1.71 % |
| 5 | France | 2 | 1M $ | 1.50 % |
| 6 | Denmark | 2 | 830.2K $ | 1.23 % |
| 7 | Germany | 1 | 586.4K $ | 0.87 % |
| 8 | Canada | 3 | 453.4K $ | 0.67 % |
| 9 | United Kingdom | 5 | 368.8K $ | 0.55 % |
| 10 | Switzerland | 2 | 302.7K $ | 0.45 % |
| 11 | Cayman Islands | 5 | 220.4K $ | 0.33 % |
| 12 | Jersey | 1 | 103.5K $ | 0.15 % |
Cite this page
Titelia. "Holdings of Invesco Nasdaq Biotechnology ETF". https://titelia.com/en/funds/S000072469